Advertisement

Table of Contents

September 01, 2016; 128 (9)

BLOOD FLASHBACK

INSIDE BLOOD COMMENTARIES

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

  • Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma
    Hervé Avet-Loiseau, Rafael Fonseca, David Siegel, Meletios A. Dimopoulos, Ivan Špička, Tamás Masszi, Roman Hájek, Laura Rosiñol, Vesselina Goranova-Marinova, Georgi Mihaylov, Vladimír Maisnar, Maria-Victoria Mateos, Michael Wang, Ruben Niesvizky, Albert Oriol, Andrzej Jakubowiak, Jiri Minarik, Antonio Palumbo, William Bensinger, Vishal Kukreti, Dina Ben-Yehuda, A. Keith Stewart, Mihaela Obreja and Philippe Moreau

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY

  • Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment
    Shahram Kordasti, Benedetta Costantini, Thomas Seidl, Pilar Perez Abellan, Marc Martinez Llordella, Donal McLornan, Kirsten E. Diggins, Austin Kulasekararaj, Cinzia Benfatto, Xingmin Feng, Alexander Smith, Syed A. Mian, Rossella Melchiotti, Emanuele de Rinaldis, Richard Ellis, Nedyalko Petrov, Giovanni A. M. Povoleri, Sun Sook Chung, N. Shaun B. Thomas, Farzin Farzaneh, Jonathan M. Irish, Susanne Heck, Neal S. Young, Judith C. W. Marsh and Ghulam J. Mufti

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

LETTERS TO BLOOD

BLOOD WORK